As a research institute for translational medicine, we dedicate our work to new therapeutics for cardiovascular diseases, which are still the major cause of death worldwide. Our mission is to identify new drug targets, to analyze their function and to develop novel therapeutic strategies.

This would not be possible without bright minds and scientific exchange. We offer some of the best pharmacology teaching to students, ranging from lectures and award-winning e-learning tools to lab internships, bachelors, masters or PhD theses. The IPT is part of the Munich Heart Alliance, a joint effort of clinicians and scientists to improve the development of novel cardiac therapies. This outstanding research community has then been appointed by the German Ministry for Education and Research (BMBF) as partner site of the German Center for Cardiovascular Research (DZHK). In addition, we maintain productive collaborations with industrial partners.

The IPT is part of the Cluster for Nucleic Acid Therapeutics Munich (CNATM). CNATM is on of the seven winners of the Clusters4Future initiative of the German Ministry for Education and Research (BMBF). The research consortium consists of research groups from the leading universities LMU and TU, researchers from the universities of Regensburg and Würzburg, as well as the Helmholtz center Munich, and 14 industrial partners from the Munich area.